Displaying drugs 51 - 75 of 12696 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Cryptenamine | Not Available |  | For the treatment of hypertension. | Antihypertensive Agents / Cevanes |
| BLX-883 | Not Available |  | Investigated for use/treatment in hepatitis (viral, C). | Not Available |
| Tyrothricin | Not Available |  | A topical antibiotic with broad spectrum activity against Gram positive bacteria and some fungal infections. | Anti-Bacterial Agents |
| Demplatin pegraglumer | Not Annotated |  | Demplatin pegraglumer is under investigation in clinical trial NCT02043288 (Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer). | Amino Acids / Amino Acids, Acidic / Amino Acids, Dicarboxylic / Amino Acids, Peptides, and Proteins / Glutamates / Organometallic Compounds / Peptides |
| INCB052793 | Not Annotated |  | Not Annotated | Not Annotated |
| SKL-27969 | Not Annotated |  | Not Annotated | Not Annotated |
| NOV-002 | Not Available |  | Investigated for use/treatment in breast cancer, lung cancer, and ovarian cancer. | Amino Acids, Peptides, and Proteins / Chlorine Compounds / Nitrogen Compounds / Oligopeptides / Peptides / Pharmaceutical Preparations |
| Aluminum chlorohydrex propylene glycol | Not Annotated |  | Aluminum chlorohydrex propylene glycol is a complex consisting of Aluminum Chorohydrate and propylene glycol (PG). It is an antiperspirant active ingredient found in antiperspirant drug products for over-the-counter human use. | Not Annotated |
| BEA-17 | Not Available |  | BEA-17 is a small molecule targeted degrader of the epigenetic enzyme LSD1 and its co-factor CoREST. It is under investigation for the treatment of glioblastoma. | Not Available |
| Corticorelin | Not Available |  | A synthetic corticotropin-releasing factor analog used to diagnose causes of excessive adrenocorticotropic hormone (ACTH) production. | Tests for Pituitary Function |
| Iron protein succinylate | Not Annotated |  | Not Annotated | Iron Trivalent, Oral Preparations |
| KDT-3594 | Not Annotated |  | KDT-3594 is a non-ergot dopamine receptor agonist developed by Kissei Pharmaceutical. | Not Annotated |
| LY2181308 | Not Available |  | Investigated for use/treatment in cancer/tumors (unspecified) and solid tumors. | Nucleic Acids, Nucleotides, and Nucleosides / Nucleotides / Polynucleotides |
| VTP-201227 | Not Available |  | Investigated for use/treatment in psoriasis and psoriatic disorders. | Not Available |
| MAS825 | Not Available |  | Not Available | Experimental Unapproved Treatments for COVID-19 |
| ND7001 | Not Available |  | Investigated for use/treatment in anxiety disorders and depression. | Not Available |
| RUS 3108 | Not Available |  | Investigated for use/treatment in atherosclerosis. | Not Available |
| Tapencarium | Not Annotated |  | Not Annotated | Heterocyclic Compounds, Fused-Ring / Indoles |
| Ergoloid mesylate | Not Available |  | A nootropic with an unknown mechanism of action indicated in individuals over sixty who manifest signs and symptoms of an idiopathic decline in mental capacity. | Agents that produce hypertension |
| REN-850 | Not Available |  | Investigated for use/treatment in multiple sclerosis. | Not Available |
| Acetylcysteine zidrimer | Not Available |  | Not Available | Experimental Unapproved Treatments for COVID-19 |
| ICG-001 | Not Annotated |  | Not Annotated | Pyrimidines |
| XL820 | Not Available |  | Investigated for use/treatment in solid tumors. | Not Available |
| CYT997 | Not Available |  | Investigated for use/treatment in solid tumors. | Not Available |
| Cu-64 sartate | Not Annotated |  | Not Annotated | Not Annotated |
Displaying drugs 51 - 75 of 12696 in total